TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA
67 insider filings · Latest: Aug 5, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | Mar 4 11:44 PM | Hughes Eric A | Proposed Sale | 23,251 | $16.00 | $372.0K | — | View → |
| Mar 4, 2025 | Mar 4 11:37 PM | Daniell Richard | Proposed Sale | 86,400 | $16.00 | $1.4M | — | View → |
| Mar 4, 2025 | Mar 4 11:30 PM | Francis Richard D | Proposed Sale | 23,773 | $16.00 | $380.4K | — | View → |
| Mar 3, 2025 | Mar 3 6:14 PM | Francis Richard D | Proposed Sale | 31,342 | $16.46 | $515.9K | — | View → |
| Mar 3, 2025 | Mar 3 6:07 PM | Hughes Eric A | Proposed Sale | 24,900 | $16.46 | $409.9K | — | View → |
| Mar 3, 2025 | Mar 3 5:59 PM | Daniell Richard | Proposed Sale | 62,250 | $16.46 | $1.0M | — | View → |
| Feb 28, 2025 | Feb 28 4:52 PM | Kalif Eliyahu Sharon | Proposed Sale | 55,750 | $16.21 | $903.5K | — | View → |
| Feb 18, 2025 | Feb 18 5:38 PM | Francis Richard D | Proposed Sale | 75,506 | $16.95 | $1.3M | — | View → |
| Feb 12, 2025 | Feb 13 1:06 PM | Sabag Mark | Proposed Sale | 177,626 | $16.25 | $2.9M | — | View → |
| Dec 20, 2024 | Dec 21 12:03 AM | Bridger Management, LLC (1) | Proposed Sale | 286,000 | $21.31 | $6.1M | — | View → |
| Nov 20, 2024 | Nov 20 4:39 PM | Fox Christine | Proposed Sale | 19,388 | $16.87 | $327.1K | — | View → |
← Previous
Page 5 of 5
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Mar 6 9:13 PM | Mark SabagSee "Remarks" | Option Exercise | 52,113 | — | 37,202(D) | View → |
| Mar 4, 2026 | Mar 6 9:11 PM | Evan LippmanEVP, Business Development | Grant/Award | 27,347 | — | 27,347(D) | View → |
| Mar 4, 2026 | Mar 6 9:09 PM | Eric A HughesSee "Remarks" | Option Exercise | 23,251 | — | 46,503(D) | View → |
| Mar 4, 2026 | Mar 6 9:09 PM | Eric A HughesSee "Remarks" | Grant/Award | 50,643 | — | 50,643(D) | View → |
| Mar 4, 2026 | Mar 6 9:08 PM | Eliyahu Sharon KalifEVP, Chief Financial Officer | Option Exercise | 56,763 | — | 46,503(D) | View → |
| Mar 4, 2026 | Mar 6 9:08 PM | Eliyahu Sharon KalifEVP, Chief Financial Officer | Grant/Award | 53,175 | — | 53,175(D) | View → |
| Mar 4, 2026 | Mar 6 9:05 PM | Christine FoxEVP, U.S. Commercial | Option Exercise | 20,461 | — | 40,923(D) | View → |
| Mar 4, 2026 | Mar 6 9:05 PM | Christine FoxEVP, U.S. Commercial | Grant/Award | 50,643 | — | 50,643(D) | View → |
| Mar 4, 2026 | Mar 6 9:03 PM | Brian SavageInterim Chief Legal Officer | Option Exercise | 8,510 | — | 7,534(D) | View → |
| Mar 4, 2026 | Mar 6 9:03 PM | Brian SavageInterim Chief Legal Officer | Grant/Award | 11,280 | — | 11,280(D) | View → |
| Mar 4, 2026 | Mar 6 9:01 PM | Amir WeissChief Accounting Officer | Grant/Award | 11,280 | — | 11,280(D) | View → |
| Mar 4, 2026 | Mar 6 9:01 PM | Amir WeissChief Accounting Officer | Option Exercise | 16,329 | — | 11,300(D) | View → |
| Mar 3, 2026 | Mar 5 9:11 PM | Amir WeissChief Accounting Officer | Option Exercise | 5,179 | — | 5,180(D) | View → |
| Mar 3, 2026 | Mar 5 9:09 PM | Richard DaniellEVP, Europe Commercial | Option Exercise | 203,728 | — | 0(D) | View → |
| Mar 3, 2026 | Mar 5 9:08 PM | Mark SabagSee "Remarks" | Option Exercise | 166,378 | — | 0(D) | View → |
| Mar 3, 2026 | Mar 5 9:06 PM | Brian SavageInterim Chief Legal Officer | Option Exercise | 3,461 | — | 3,461(D) | View → |
| Mar 3, 2026 | Mar 5 9:05 PM | Richard D FrancisPresident and CEO | Option Exercise | 958,546 | — | 0(D) | View → |
| Mar 3, 2026 | Mar 5 9:03 PM | Eliyahu Sharon KalifEVP, Chief Financial Officer | Option Exercise | 191,278 | — | 0(D) | View → |
| Mar 3, 2026 | Mar 5 9:01 PM | Eric A HughesSee "Remarks" | Option Exercise | 166,378 | — | 0(D) | View → |
| Feb 15, 2026 | Feb 18 9:01 PM | Richard D FrancisPresident and CEO | Option Exercise | 781,766 | — | 0(D) | View → |